Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non–Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker
Titel:
Phase I Study of Lapatinib and Pemetrexed in the Second-Line Treatment of Advanced or Metastatic Non–Small-Cell Lung Cancer With Assessment of Circulating Cell Free Thymidylate Synthase RNA as a Potential Biomarker
Auteur:
Ramlau, Rodryg Thomas, Michael Novello, Silvia Plummer, Ruth Reck, Martin Kaneko, Tomomi Lau, Mike R. Margetts, Jane Lunec, John Nutt, Joyce Scagliotti, Giorgio V.